A citation-based method for searching scientific literature

Thomas Fremming Dejgaard, Christian Seerup Frandsen, Tanja Stenbæk Hansen, Thomas Almdal, Søren Urhammer, Ulrik Pedersen-Bjergaard, Tonny Jensen, Andreas Kryger Jensen, Jens Juul Holst, Lise Tarnow, Filip Krag Knop, Sten Madsbad, Henrik Ullits Andersen. Lancet Diabetes Endocrinol 2016
Times Cited: 67



Xavier Pi-Sunyer, Arne Astrup, Ken Fujioka, Frank Greenway, Alfredo Halpern, Michel Krempf, David C W Lau, Carel W le Roux, Rafael Violante Ortiz, Christine Bjørn Jensen, John P H Wilding. N Engl J Med 2015
Times Cited: 661




List of shared articles



Times cited

GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.
Michael A Nauck, Daniel R Quast, Jakob Wefers, Juris J Meier. Mol Metab 2021
15

Pharmacological therapies to address obesity in type 1 diabetes.
Anna Casu, Anika Bilal, Richard E Pratley. Curr Opin Endocrinol Diabetes Obes 2020
0

Newer GLP-1 receptor agonists and obesity-diabetes.
Emily Brown, Daniel J Cuthbertson, John P Wilding. Peptides 2018
20


An update on pharmacotherapeutic strategies for obesity.
Beverly G Tchang, Mohamad Sirri Tarazi, Mohini Aras, Alpana P Shukla. Expert Opin Pharmacother 2021
0

Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity.
Daniel B Maselli, Michael Camilleri. Adv Exp Med Biol 2021
5

Current and future therapies for type 1 diabetes.
Bernt Johan von Scholten, Frederik F Kreiner, Stephen C L Gough, Matthias von Herrath. Diabetologia 2021
2

GLP-1 based therapies: clinical implications for gastroenterologists.
Mark M Smits, Daniel H van Raalte, Lennart Tonneijck, Marcel H A Muskiet, Mark H H Kramer, Djuna L Cahen. Gut 2016
24